{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:00:46Z","timestamp":1788433246200,"version":"build-2803163510"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Over the last 10\u00a0years, the number of women with diabetes during pregnancy has increased steadily. Maternal glycaemic control is the most important factor influencing maternal and neonatal outcomes, and technological advances have become integral to the evolution of diabetes care during pregnancy. However, rapid technological development must be accompanied by the equally rapid dissemination of information. In particular, knowledge of the availability of automated insulin delivery (AID) systems for managing type 1 diabetes in pregnancy, and of glucose continuous monitoring (CGM) systems for gestational and type 2 diabetes, needs to be increased. The AMD-SID Italian Diabetes and Pregnancy Study Group, supported by the Technology and Diabetes Study Group, has produced this position paper of expert opinion to review the main international guidelines and current evidence on new technologies for the management of pregnancy in women with GDM, type 1 and type 2 diabetes, and to provide detailed suggestions for the use of commercially available systems in clinical practice.<\/jats:p>","DOI":"10.1007\/s00592-025-02592-2","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T07:08:29Z","timestamp":1762758509000},"page":"929-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The use of technology in diabetes in pregnancy: a position statement of expert opinion from the association of medical diabetologists (AMD), the Italian society of diabetology (SID) and the interassociative diabetes and pregnancy study group"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8443-7773","authenticated-orcid":false,"given":"Veronica","family":"Resi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Grancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Manicardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta Maria","family":"Scarpitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Pio","family":"Sorice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Fresa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"2592_CR1","unstructured":"https:\/\/aemmedi.it\/wp-content\/uploads\/2025\/05\/Annali_2024_Valutazione-indicatori-prot.pdf"},{"issue":"10","key":"2592_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00125-024-06216-2","volume":"67","author":"A McLean","year":"2024","unstructured":"McLean A, Maple-Brown L, Murphy HR (2024) Technology advances in diabetes pregnancy: right technology, right person, right time. Diabetologia 67(10):2103\u20132113. https:\/\/doi.org\/10.1007\/s00125-024-06216-2","journal-title":"Diabetologia"},{"issue":"8","key":"2592_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237571","volume":"15","author":"HA Wahabi","year":"2020","unstructured":"Wahabi HA, Fayed A, Esmaeil S, Elmorshedy H, Titi MA et al (2020) Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes. PLoS ONE 15(8):e0237571. https:\/\/doi.org\/10.1371\/journal.pone.0237571","journal-title":"PLoS ONE"},{"key":"2592_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251327603","author":"NC Sobhani","year":"2025","unstructured":"Sobhani NC (2025) Impact of AID on glycemic profile and maternal\/neonatal outcomes in pregnancy: a review of the evidence from observational studies. J Diabetes Sci Technol. https:\/\/doi.org\/10.1177\/19322968251327603","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2592_CR5","doi-asserted-by":"publisher","first-page":"CD009613","DOI":"10.1002\/14651858.CD009613.pub4","volume":"5","author":"LV Jones","year":"2019","unstructured":"Jones LV, Ray A, Moy FM, Buckley BS (2019) Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes. Cochrane Database Syst Rev 5(5):CD009613. https:\/\/doi.org\/10.1002\/14651858.CD009613.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1 Suppl 1","key":"2592_CR6","doi-asserted-by":"publisher","first-page":"S306","DOI":"10.2337\/dc25-S015","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) 15. Management of diabetes in pregnancy: standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1):S306\u2013S320. https:\/\/doi.org\/10.2337\/dc25-S015","journal-title":"Diabetes Care"},{"issue":"6","key":"2592_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1373\/clinchem.2005.064899","volume":"52","author":"A Mosca","year":"2006","unstructured":"Mosca A, Paleari R, Dalfr\u00e0 MG, Di Cianni G, Cuccuru I, Pellegrini G et al (2006) Reference intervals for hemoglobin A1c in pregnant women: data from an italian multicenter study. Clin Chem 52(6):1138\u20131143","journal-title":"Clin Chem"},{"issue":"5","key":"2592_CR8","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2337\/diacare.27.5.1200","volume":"27","author":"LR Nielsen","year":"2004","unstructured":"Nielsen LR, Ekbom P, Damm P, Gl\u00fcmer C, Frandsen MM, Jensen DM et al (2004) Hba1c levels are significantlylower in early and late pregnancy. Diabetes Care 27(5):1200\u20131201","journal-title":"Diabetes Care"},{"key":"#cr-split#-2592_CR9.1","unstructured":"AMD - SID (2018) Standard Italiani per la cura del Diabete Mellito"},{"key":"#cr-split#-2592_CR9.2","unstructured":"[cited 2025 Jul 5]. https:\/\/aemmedi.it\/wp-content\/uploads\/2009\/06\/AMD-Standard-unico1.pdf"},{"issue":"2","key":"2592_CR10","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"ACOG","year":"2018","unstructured":"ACOG (2018) Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 131(2):e49-64","journal-title":"Obstet Gynecol"},{"key":"#cr-split#-2592_CR11.1","unstructured":"NICE (2020) Diabetes in pregnancy: management from preconception to the postnatal period"},{"key":"#cr-split#-2592_CR11.2","unstructured":"[cited 2025 Jun 12]. https:\/\/www.nice.org.uk\/guidance\/ng3\/resources\/diabetes-in-pregnancy-management-from-preconception-to-the-postnatal-period-51038446021"},{"issue":"5","key":"2592_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.numecd.2019.01.018","volume":"29","author":"D Bruttomesso","year":"2019","unstructured":"Bruttomesso D, Laviola L, Avogaro A, Bonora E, Del Prato S, Frontoni S et al (2019) The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: a consensus view of Italian diabetes experts using the Delphi method. Nutr Metab Cardiovasc Dis 29(5):421\u2013431","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"2592_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1089\/dia.2017.0386","volume":"20","author":"EM Scott","year":"2018","unstructured":"Scott EM, Bilous RW, Kautzky-Willer A (2018) Accuracy, user acceptability, and safety evaluation for the FreeStyle Libre flash glucose monitoring system when used by pregnant women with diabetes. Diabetes Technol Ther 20(3):180\u2013188","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2592_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/dia.2020.0085","volume":"22","author":"K Castorino","year":"2020","unstructured":"Castorino K, Polsky S, O\u2019Malley G, Levister C, Nelson K, Farfan C et al (2020) Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes. Diabetes Technol Ther 22(12):943\u2013947","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR15","first-page":"14","volume":"19","author":"M Lai","year":"2023","unstructured":"Lai M, Weng J, Yang J, Gong Y, Fang F, Li N et al (2023) Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial. Front Endocrinol 19:14","journal-title":"Front Endocrinol"},{"issue":"17","key":"2592_CR16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","volume":"389","author":"TTM Lee","year":"2023","unstructured":"Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS et al (2023) Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med 389(17):1566\u20131578","journal-title":"N Engl J Med"},{"issue":"6","key":"2592_CR17","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","volume":"12","author":"K Benhalima","year":"2024","unstructured":"Benhalima K, Beunen K, Van Wilder N, Ballaux D, Vanhaverbeke G, Taes Y et al (2024) Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol 12(6):390\u2013403","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"S1","key":"2592_CR18","first-page":"S-8","volume":"23","author":"JM Yamamoto","year":"2021","unstructured":"Yamamoto JM, Murphy HR (2021) Benefits of real-time continuous glucose monitoring in pregnancy. Diabetes Technol Ther 23(S1):S-8-S\u221214","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR19","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Moreno RM, Ben\u00edtez-Valderrama P, Barquiel B, Gonz\u00e1lez P\u00e9rez-de-Villar N, Hillman N, Lora Pablos D et al (2022) Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta\u2010analysis of randomized clinical trials. Diabet Med 39(1):e14703. https:\/\/doi.org\/10.1111\/dme.14703. Epub 2021 Oct 13; PMID: 34564868","DOI":"10.1111\/dme.14703"},{"issue":"10","key":"2592_CR20","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.3390\/jcm11102932","volume":"11","author":"A Majewska","year":"2022","unstructured":"Majewska A, Stanirowski PJ, Wielgo\u015b M, Bomba-Opo\u0144 D (2022) Efficacy of continuous glucose monitoring on glycaemic control in pregnant women with gestational diabetes mellitus\u2014a systematic review. J Clin Med 11(10):2932","journal-title":"J Clin Med"},{"issue":"8","key":"2592_CR21","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/dme.13649","volume":"35","author":"SS Paramasivam","year":"2018","unstructured":"Paramasivam SS, Chinna K, Singh AKK, Ratnasingam J, Ibrahim L, Lim LL et al (2018) Continuous glucose monitoring results in lower HbA 1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial. Diabet Med 35(8):1118\u20131129","journal-title":"Diabet Med"},{"issue":"09","key":"2592_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1055\/s-0039-1678733","volume":"36","author":"AS Lane","year":"2019","unstructured":"Lane AS, Mlynarczyk MA, de Veciana M, Green LM, Baraki DI, Abuhamad AZ (2019) Real-time continuous glucose monitoring in gestational diabetes: a randomized controlled trial. Am J Perinatol 36(09):891\u2013897","journal-title":"Am J Perinatol"},{"issue":"5","key":"2592_CR23","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.21037\/apm-21-439","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X, Jiang D, Wang X (2021) The effects of the instantaneous scanning glucose monitoring system on hypoglycemia, weight gain, and health behaviors in patients with gestational diabetes: a randomised trial. Ann Palliat Med 10(5):5714\u20135720","journal-title":"Ann Palliat Med"},{"issue":"1","key":"2592_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13098-016-0161-5","volume":"8","author":"E Alfadhli","year":"2016","unstructured":"Alfadhli E, Osman E, Basri T (2016) Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetol Metab Syndr 8(1):48","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"2592_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.diabres.2006.12.012","volume":"77","author":"KK Kestil\u00e4","year":"2007","unstructured":"Kestil\u00e4 KK, Ekblad UU, R\u00f6nnemaa T (2007) Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 77(2):174\u2013179","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"2592_CR26","doi-asserted-by":"publisher","first-page":"19920","DOI":"10.1038\/srep19920","volume":"6","author":"Q Wei","year":"2016","unstructured":"Wei Q, Sun Z, Yang Y, Yu H, Ding H, Wang S (2016) Effect of a CGMS and SMBG on maternal and neonatal outcomes in gestational diabetes mellitus: a randomized controlled trial. Sci Rep 6(1):19920","journal-title":"Sci Rep"},{"key":"2592_CR27","volume":"39","author":"X Liang","year":"2023","unstructured":"Liang X, Fu Y, Lu S, Shuai M, Miao Z, Gou W et al (2023) Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study. Lancet Reg Health 39:100823","journal-title":"Lancet Reg Health"},{"issue":"8","key":"2592_CR28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.2337\/dc23-2149","volume":"47","author":"C Durnwald","year":"2024","unstructured":"Durnwald C, Beck RW, Li Z, Norton E, Bergenstal RM, Johnson M et al (2024) Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus. Diabetes Care 47(8):1333\u20131341","journal-title":"Diabetes Care"},{"issue":"1","key":"2592_CR29","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12884-023-05824-x","volume":"23","author":"EM Scott","year":"2023","unstructured":"Scott EM, Murphy HR, Myers J, Saravanan P, Poston L, Law GR (2023) MAGIC (maternal glucose in pregnancy) understanding the glycemic profile of pregnancy, intensive CGM glucose profiling and its relationship to fetal growth: an observational study protocol. BMC Pregnancy Childbirth 23(1):563","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"2592_CR30","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593\u20131603","journal-title":"Diabetes Care"},{"issue":"10110","key":"2592_CR31","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF et al (2017) Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet 390(10110):2347\u20132359","journal-title":"Lancet"},{"issue":"sep25 2","key":"2592_CR32","doi-asserted-by":"publisher","first-page":"a1680","DOI":"10.1136\/bmj.a1680","volume":"337","author":"HR Murphy","year":"2008","unstructured":"Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K et al (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337(sep25 2):a1680\u2013a1680","journal-title":"BMJ"},{"key":"2592_CR33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.2337\/dc07-0500","volume":"30","author":"HR Murphy","year":"2007","unstructured":"Murphy HR, Rayman G, Duffield K et al (2007) Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 30:2785\u20132791","journal-title":"Diabetes Care"},{"issue":"8","key":"2592_CR34","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/dom.13310","volume":"20","author":"DN Voormolen","year":"2018","unstructured":"Voormolen DN, DeVries JH, Sanson RME, Heringa MP, de Valk HW, Kok M et al (2018) Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes Obes Metab 20(8):1894\u20131902","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2592_CR35","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2337\/dc12-2360","volume":"36","author":"AL Secher","year":"2013","unstructured":"Secher AL, Ringholm L, Andersen HU, Damm P, Mathiesen ER (2013) The effect of real-time continuous glucose monitoring in pregnant women with diabetes. Diabetes Care 36(7):1877\u20131883","journal-title":"Diabetes Care"},{"issue":"2","key":"2592_CR36","doi-asserted-by":"publisher","first-page":"E627","DOI":"10.9778\/cmajo.20200128","volume":"9","author":"RJ Ahmed","year":"2021","unstructured":"Ahmed RJ, Gafni A, Hutton EK, Hu ZJ, Sanchez JJ, Murphy HR et al (2021) The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial. CMAJ Open 9(2):E627\u2013E634","journal-title":"CMAJ Open"},{"issue":"2","key":"2592_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diabet.2019.08.001","volume":"46","author":"A Sola-Gazagnes","year":"2020","unstructured":"Sola-Gazagnes A, Faucher P, Jacqueminet S, Ciangura C, Dubois-Laforgue D, Mosnier-Pudar H et al (2020) Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy. Diabetes Metab 46(2):158\u2013163","journal-title":"Diabetes Metab"},{"issue":"10","key":"2592_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/dia.2021.0109","volume":"23","author":"SK N\u00f8rgaard","year":"2021","unstructured":"N\u00f8rgaard SK, Mathiesen ER, N\u00f8rgaard K, Ringholm L (2021) Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes. Diabetes Technol Ther 23(10):665\u2013672","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2592_CR39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s00125-022-05717-2","volume":"65","author":"V Perea","year":"2022","unstructured":"Perea V, Pic\u00f3n MJ, Megia A, Goya M, W\u00e4gner AM, Vega B et al (2022) Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes. Diabetologia 65(8):1302\u20131314","journal-title":"Diabetologia"},{"issue":"1","key":"2592_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/1932296820958754","volume":"16","author":"S Alva","year":"2022","unstructured":"Alva S, Bailey T, Brazg R, Budiman ES, Castorino K, Christiansen MP et al (2022) Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes. J Diabetes Sci Technol 16(1):70\u201377","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"2592_CR41","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.2337\/dc22-0078","volume":"45","author":"EM Scott","year":"2022","unstructured":"Scott EM, Murphy HR, Kristensen KH, Feig DS, Kj\u00f6lhede K, Englund-\u00d6gge L et al (2022) Continuous glucose monitoring metrics and birth weight: informing management of type 1 diabetes throughout pregnancy. Diabetes Care 45(8):1724\u20131734","journal-title":"Diabetes Care"},{"issue":"12","key":"2592_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1089\/dia.2021.0093","volume":"23","author":"VN Shah","year":"2021","unstructured":"Shah VN, Snell-Bergeon JK, Demmitt JK, Joshee P, Garcetti R, Pyle L et al (2021) Relationship between time-in-range, HbA1c, and the glucose management indicator in pregnancies complicated by type 1 diabetes. Diabetes Technol Ther 23(12):783\u2013790","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2592_CR43","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/dia.2021.0194","volume":"24","author":"R Sibiak","year":"2022","unstructured":"Sibiak R, Gutaj P, Mrzewka-Rogacz B, Mantaj U, Wender-Ozegowska E (2022) Novel continuous glucose monitoring metrics and large-for-gestational-age risk: an exploratory retrospective cohort study in pregnancies with type 1 diabetes. Diabetes Technol Ther 24(1):42\u201353","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR44","doi-asserted-by":"publisher","unstructured":"Buschur E, Campbell K, Pyle L, Garcetti R, Joshee P, Demmitt J et al (2021) Exploratory analysis of glycemic control and variability over gestation among pregnant women with type 1 diabetes (T1D). Diabetes Technol Ther 23(11):768\u2013772. https:\/\/doi.org\/10.1089\/dia.2021.0138. PMID: 34115946; PMCID: PMC9009588.","DOI":"10.1089\/dia.2021.0138"},{"issue":"3","key":"2592_CR45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2337\/dc20-2360","volume":"44","author":"CL Meek","year":"2021","unstructured":"Meek CL, Tundidor D, Feig DS, Yamamoto JM, Scott EM, Ma DD et al (2021) Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes. Diabetes Care 44(3):681\u2013689","journal-title":"Diabetes Care"},{"issue":"11","key":"2592_CR46","doi-asserted-by":"publisher","first-page":"e4309","DOI":"10.1210\/clinem\/dgab502","volume":"106","author":"P Ling","year":"2021","unstructured":"Ling P, Yang D, Gu N, Xiao X, Lu J, Liu F et al (2021) Achieving the HbA1c target requires longer time in range in pregnant women with type 1 diabetes. J Clin Endocrinol Metab 106(11):e4309\u2013e4317","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2592_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/1932296819890864","volume":"14","author":"S Polsky","year":"2020","unstructured":"Polsky S, Garcetti R, Pyle L, Joshee P, Demmitt JK, Snell-Bergeon JK (2020) Continuous glucose monitor use with remote monitoring reduces fear of hypoglycemia in pregnant women with type 1 diabetes: a pilot study. J Diabetes Sci Technol 14(1):191\u2013192","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"2592_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1089\/dia.2021.0479","volume":"24","author":"RJ Kaur","year":"2022","unstructured":"Kaur RJ, Smith BH, Ozaslan B, Pinsker JE, Trinidad MC, O\u2019Malley G et al (2022) Hypoglycemia in prospective multicenter study of pregnancies with pre-existing type 1 diabetes on sensor-augmented pump therapy: the LOIS-P study. Diabetes Technol Ther 24(8):544\u2013555","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR49","doi-asserted-by":"publisher","unstructured":"Bahrami J, Tomlinson G, Murphy HR, Feig DS (2022) Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes. Diabet Med 39(5):e14789. https:\/\/doi.org\/10.1111\/dme.14789.  Epub 2022 Jan 30. PMID: 35030277; PMCID: PMC9305507.","DOI":"10.1111\/dme.14789"},{"issue":"7","key":"2592_CR50","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jcjd.2021.02.007","volume":"45","author":"CB Chan","year":"2021","unstructured":"Chan CB, Popeski N, Hassanabad MF, Sigal RJ, O\u2019Connell P, Sargious P (2021) Use of virtual care for glycemic management in people with types 1 and 2 diabetes and diabetes in pregnancy: a rapid review. Can J Diabetes 45(7):677-688.e2","journal-title":"Can J Diabetes"},{"issue":"5","key":"2592_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1089\/dia.2014.0223","volume":"17","author":"F Carral","year":"2015","unstructured":"Carral F, Ayala MdelC, Fern\u00e1ndez JJ, Gonz\u00e1lez C, Pi\u00f1ero A, Garc\u00eda G et al (2015) Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes. Diabetes Technol Ther 17(5):349\u2013354","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2592_CR52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","volume":"27","author":"G Grunberger","year":"2021","unstructured":"Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y et al (2021) American association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract 27(6):505\u2013537","journal-title":"Endocr Pract"},{"issue":"1","key":"2592_CR53","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvaf116","volume":"193","author":"JA Wyckoff","year":"2025","unstructured":"Wyckoff JA, Lapolla A, Asias-Dinh BD, Barbour LA, Brown FM, Catalano PM, Corcoy R, Di Renzo GC, Drobycki N, Kautzky-Willer A, Murad MH, Stephenson-Gray M, Tab\u00e1k AG, Weatherup E, Zera C, Singh-Ospina N (2025) Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology joint clinical practice guideline. Eur J Endocrinol 193(1):G1\u2013G48. https:\/\/doi.org\/10.1093\/ejendo\/lvaf116","journal-title":"Eur J Endocrinol"},{"key":"2592_CR54","unstructured":"Diabetes Canada Clinical Practice Guidelines. 2021 chapter updates. https:\/\/guidelines.diabetes.ca\/2021-Update Accessed 12 Oct 2022"},{"key":"2592_CR55","unstructured":"ABCD DTN-UK (2020) BEST PRACTICE GUIDE: USING DIABETES TECHNOLOGY IN PREGNANCY Version 2.0, [cited 2025 Jun 16]. https:\/\/abcd.care\/sites\/default\/files\/site_uploads\/Resources\/DTN\/BP-Pregnancy-DTN-V2.0.p"},{"issue":"4","key":"2592_CR56","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2337\/ds18-0069","volume":"32","author":"NA Sangave","year":"2019","unstructured":"Sangave NA, Aungst TD, Patel DK (2019) Smart connected insulin pens, caps, and attachments: a review of the future of diabetes technology. Diabetes Spectr 32(4):378\u2013384","journal-title":"Diabetes Spectr"},{"key":"2592_CR57","first-page":"13","volume":"8","author":"M Masierek","year":"2022","unstructured":"Masierek M, Nabrdalik K, Janota O, Kwiendacz H, Macherski M, Gumprecht J (2022) The review of insulin pens\u2014past, present, and look to the future. Front Endocrinol 8:13","journal-title":"Front Endocrinol"},{"issue":"7","key":"2592_CR58","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s13300-023-01417-1","volume":"14","author":"C Tejera-P\u00e9rez","year":"2023","unstructured":"Tejera-P\u00e9rez C, Chico A, Azriel-Mira S, Lardi\u00e9s-S\u00e1nchez B, Gomez-Peralta F, Jes\u00fas AFA et al (2023) Connected insulin pens and caps: an expert\u2019s recommendation from the area of diabetes of the Spanish endocrinology and nutrition society (SEEN). Diabetes Ther 14(7):1077\u20131091","journal-title":"Diabetes Ther"},{"issue":"5","key":"2592_CR59","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1177\/1932296814532906","volume":"8","author":"S Schmidt","year":"2014","unstructured":"Schmidt S, N\u00f8rgaard K (2014) Bolus calculators. J Diabetes Sci Technol 8(5):1035\u20131041","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2592_CR60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2337\/diaclin.32.4.152","volume":"32","author":"SD Zaugg","year":"2014","unstructured":"Zaugg SD, Dogbey G, Collins K, Reynolds S, Batista C, Brannan G et al (2014) Diabetes numeracy and blood glucose control: association with type of diabetes and source of care. Clin Diabetes 32(4):152\u2013157","journal-title":"Clin Diabetes"},{"issue":"2","key":"2592_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/193229680800200209","volume":"2","author":"J Randl\u00f8v","year":"2008","unstructured":"Randl\u00f8v J, Poulsen JU (2008) How much do forgotten insulin injections matter to hemoglobin A1c in people with diabetes? A simulation study. J Diabetes Sci Technol 2(2):229\u2013235","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2592_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/dia.2019.0411","volume":"22","author":"P Adolfsson","year":"2020","unstructured":"Adolfsson P, Hartvig NV, Kaas A, M\u00f8ller JB, Hellman J (2020) Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen. Diabetes Technol Ther 22(10):709\u2013718","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2592_CR63","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/19322968211033837","volume":"17","author":"RJ Galindo","year":"2023","unstructured":"Galindo RJ, Ramos C, Cardona S, Vellanki P, Davis GM, Oladejo O et al (2023) Efficacy of a smart insulin pen cap for the management of patients with uncontrolled type 2 diabetes: a randomized cross-over trial. J Diabetes Sci Technol 17(1):201\u2013207","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2592_CR64","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/healthcare13010038","volume":"13","author":"V Resi","year":"2024","unstructured":"Resi V, Gaglio A, Pigotskaya Y, Caretto A, Orsi E, Grancini V (2024) Smart insulin pen in pregnant women with type 1 diabetes: an encouraging case series. Healthcare 13(1):38","journal-title":"Healthcare"},{"issue":"8","key":"2592_CR65","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/dia.2018.0033","volume":"20","author":"S Polsky","year":"2018","unstructured":"Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM et al (2018) Diabetes technology use among pregnant and nonpregnant women with T1D in the T1D exchange. Diabetes Technol Ther 20(8):517\u2013523","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"2592_CR66","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.numecd.2020.06.006","volume":"30","author":"A Lapolla","year":"2020","unstructured":"Lapolla A, Amaro F, Bruttomesso D, Di Bartolo P, Grassi G, Maffeis C et al (2020) Diabetic ketoacidosis: a consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP). Nutr Metab Cardiovasc Dis 30(10):1633\u20131644","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"2592_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s13300-020-00780-7","volume":"11","author":"A Jotic","year":"2020","unstructured":"Jotic A, Milicic T, Lalic K, Lukic L, Macesic M, Stanarcic Gajovic J et al (2020) Evaluation of glycaemic control, glucose variability and hypoglycaemia on long-term continuous subcutaneous infusion vs. multiple daily injections: observational study in pregnancies with pre-existing type 1 diabetes. Diabetes Ther 11(4):845\u2013858","journal-title":"Diabetes Ther"},{"key":"2592_CR68","doi-asserted-by":"publisher","unstructured":"Farrar D, Tuffnell DJ, West J, West HM (2016) Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2016(6). https:\/\/doi.org\/10.1002\/14651858.CD005542. CD005542.pub3. PMID: 27272351; PMCID: PMC8563847","DOI":"10.1002\/14651858.CD005542"},{"issue":"1","key":"2592_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/dia.2009.0081","volume":"12","author":"K Cyganek","year":"2010","unstructured":"Cyganek K, Hebda-Szydlo A, Katra B, Skupien J, Klupa T, Janas I et al (2010) Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther 12(1):41\u201347","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2592_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00125-014-3163-6","volume":"57","author":"MM Kallas-Koeman","year":"2014","unstructured":"Kallas-Koeman MM, Kong JM, Klinke JA, Butalia S, Lodha AK, Lim KI et al (2014) Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia 57(4):681\u2013689","journal-title":"Diabetologia"},{"issue":"12","key":"2592_CR71","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2337\/dc18-1437","volume":"41","author":"DS Feig","year":"2018","unstructured":"Feig DS, Corcoy R, Donovan LE, Murphy KE, Barrett JFR, Sanchez JJ et al (2018) Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial. Diabetes Care 41(12):2471\u20132479","journal-title":"Diabetes Care"},{"issue":"5","key":"2592_CR72","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/EJE-17-0804","volume":"178","author":"PM Rys","year":"2018","unstructured":"Rys PM, Ludwig-Slomczynska AH, Cyganek K, Malecki MT (2018) Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies. Eur J Endocrinol 178(5):545\u2013563","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2592_CR73","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1177\/19322968231186626","volume":"17","author":"SA Fisher","year":"2023","unstructured":"Fisher SA, Huang J, DuBord AY, Xu NY, Beestrum M, Niznik C et al (2023) Continuous subcutaneous infusion versus multiple daily injections of insulin for pregestational diabetes in pregnancy: a systematic review and meta-analysis. J Diabetes Sci Technol 17(5):1337\u20131363","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"2592_CR74","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/dia.2016.0412","volume":"19","author":"SK Abell","year":"2017","unstructured":"Abell SK, Suen M, Pease A, Boyle JA, Soldatos G, Regan J et al (2017) Pregnancy outcomes and insulin requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: cohort study. Diabetes Technol Ther 19(5):280\u2013287","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2592_CR75","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/193229681100500118","volume":"5","author":"J Walsh","year":"2011","unstructured":"Walsh J, Roberts R, Bailey T (2011) Guidelines for optimal bolus calculator settings in adults. J Diabetes Sci Technol 5(1):129\u2013135","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"2592_CR76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.numecd.2018.03.011","volume":"28","author":"A Nicolucci","year":"2018","unstructured":"Nicolucci A, Rossi MC, D\u2019Ostilio D, Delbaere A, de Portu S, Roze S (2018) Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy. Nutr Metab Cardiovasc Dis 28(7):707\u2013715","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"2592_CR77","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/dia.2017.0030","volume":"19","author":"AM G\u00f3mez","year":"2017","unstructured":"G\u00f3mez AM, Mar\u00edn Carrillo LF, Ar\u00e9valo Correa CM, Mu\u00f1oz Velandia OM, Rond\u00f3n Sep\u00falveda MA, Silva Herrera JL et al (2017) Maternal-fetal outcomes in 34 pregnant women with type 1 diabetes in sensor-augmented insulin pump therapy. Diabetes Technol Ther 19(7):417\u2013422","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"2592_CR78","doi-asserted-by":"publisher","first-page":"675","DOI":"10.5603\/GP.a2021.0029","volume":"92","author":"I Lason","year":"2021","unstructured":"Lason I, Cyganek K, Witek P, Matejko B, Malecki MT, Skupien J (2021) Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus. Ginekol Pol 92(10):675\u2013681","journal-title":"Ginekol Pol"},{"issue":"9","key":"2592_CR79","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00592-023-02080-5","volume":"60","author":"RA Dodesini","year":"2023","unstructured":"Dodesini RA, Cimino E, Conti A, Scaranna C et al (2023) Sensor augmented pump therapy with predictive suspension function for low glucose levels reduces time in hypoglycaemia in pregnant women with type 1 diabetes. Acta Diabetol 60(9):1283\u20131285","journal-title":"Acta Diabetol"},{"issue":"12","key":"2592_CR80","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/jdi.14075","volume":"14","author":"H Imafuku","year":"2023","unstructured":"Imafuku H, Tanimura K, Masuko N, Tomimoto M, Shi Y, Uchida A et al (2023) Advantages of sensor-augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus. J Diabetes Investig 14(12):1383\u20131390","journal-title":"J Diabetes Investig"},{"issue":"3","key":"2592_CR81","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dom.14273","volume":"23","author":"L Leelarathna","year":"2021","unstructured":"Leelarathna L, Choudhary P, Wilmot EG, Lumb A, Street T, Kar P et al (2021) Hybrid closed-loop therapy: where are we in 2021? Diabetes Obes Metab 23(3):655\u2013660","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2592_CR82","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","volume":"64","author":"CK Boughton","year":"2021","unstructured":"Boughton CK, Hovorka R (2021) New closed-loop insulin systems. Diabetologia 64(5):1007\u20131015","journal-title":"Diabetologia"},{"issue":"10","key":"2592_CR83","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/dme.13406","volume":"34","author":"C Farrington","year":"2017","unstructured":"Farrington C, Stewart ZA, Barnard K, Hovorka R, Murphy HR (2017) Experiences of closed-loop insulin delivery among pregnant women with type 1 diabetes. Diabet Med 34(10):1461\u20131469. https:\/\/doi.org\/10.1111\/dme.13406","journal-title":"Diabet Med"},{"issue":"12","key":"2592_CR84","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/dia.2023.0323","volume":"25","author":"J Lawton","year":"2023","unstructured":"Lawton J, Kimbell B, Closs M, Hartnell S, Lee TTM, Dover AR, Reynolds RM, Collett C, Barnard-Kelly K, Hovorka R, Rankin D, Murphy HR (2023) Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy. Diabetes Technol Ther 25(12):845\u2013855. https:\/\/doi.org\/10.1089\/dia.2023.0323","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR85","doi-asserted-by":"publisher","first-page":"193229682513236","DOI":"10.1177\/19322968251323614","volume":"12","author":"K Benhalima","year":"2025","unstructured":"Benhalima K, Polsky S (2025) Automated insulin delivery in pregnancies complicated by type 1 diabetes. J Diabetes Sci Technol 12:19322968251323616. https:\/\/doi.org\/10.1177\/19322968251323614","journal-title":"J Diabetes Sci Technol"},{"key":"2592_CR86","unstructured":"University of Cambridge. US Food and Drug Administration approves Cambridge-developed artificial pancreas [Internet]. Cambridge: University of Cambridge News; 2024 May 29 [cited 2025 Aug 4]. Available from: https:\/\/www.cam.ac.uk\/research\/news\/us-food-and-drug-administration-approves-cambridge-developed-artificial-pancreas"},{"key":"2592_CR87","unstructured":"Medtronic plc. Medtronic receives CE mark approval for expanded MiniMed\u2122 780G system use in pregnancy [Internet]. Dublin: Medtronic Newsroom; 2025 Jul [cited 2025 Aug 4]. https:\/\/news.medtronic.com"},{"issue":"6","key":"2592_CR88","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/19322968231223934","volume":"18","author":"K Benhalima","year":"2024","unstructured":"Benhalima K, Jendle J, Beunen K, Ringholm L (2024) Automated insulin delivery for pregnant women with type 1 diabetes: where do we stand? J Diabetes Sci Technol 18(6):1334\u20131345. https:\/\/doi.org\/10.1177\/19322968231223934","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"2592_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03890-w","volume":"23","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang L, Chen W (2025) Global, regional, and national burdens of type 1 and type 2 diabetes mellitus in adolescents from 1990 to 2021, with forecasts to 2030: a systematic analysis of the global burden of disease study 2021. BMC Med 23(1):48. https:\/\/doi.org\/10.1186\/s12916-025-03890-w","journal-title":"BMC Med"},{"issue":"17","key":"2592_CR90","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMe2310798","volume":"26","author":"SK Garg","year":"2023","unstructured":"Garg SK, Polsky S (2023) Technology use and glycemic outcomes during pregnancy with type 1 diabetes. N Engl J Med 26(17):1617\u20131619. https:\/\/doi.org\/10.1056\/NEJMe2310798","journal-title":"N Engl J Med"},{"issue":"7","key":"2592_CR91","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","volume":"375","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN et al (2016) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 375(7):644\u2013654","journal-title":"N Engl J Med"},{"issue":"7","key":"2592_CR92","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1602494","volume":"375","author":"ZA Stewart","year":"2016","unstructured":"Stewart ZA, Wilinska ME, Hartnell S, Temple RC, Rayman G, Stanley KP et al (2016) Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 375(7):644\u2013654","journal-title":"N Engl J Med"},{"issue":"7","key":"2592_CR93","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2337\/dc17-2534","volume":"41","author":"ZA Stewart","year":"2018","unstructured":"Stewart ZA, Wilinska ME, Hartnell S, O\u2019Neil LK, Rayman G, Scott EM et al (2018) Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care 41(7):1391\u20131399","journal-title":"Diabetes Care"},{"key":"2592_CR94","doi-asserted-by":"publisher","unstructured":"Quir\u00f3s C, Herrera MT, Amig\u00f3 J, Wagner A, Beato-Vibora PI, Azriel S et al (2024) Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technol Ther 26(8):596\u2013606. https:\/\/doi.org\/10.1089\/dia.2023.0594. Epub 2024 May 24. PMID: 38417014","DOI":"10.1089\/dia.2023.0594"},{"key":"2592_CR95","doi-asserted-by":"publisher","unstructured":"Stamati A, Christoforidis A (2024) Efficacy and safety of automated insulin delivery systems during pregnancy: a meta-analysis of 13 studies. Acta Diabetol 62(4):441\u2013452. https:\/\/doi.org\/10.1007\/s00592-025-02446-x. Epub 2025 Jan 10. PMID: 39792171; PMCID: PMC12055664.","DOI":"10.1007\/s00592-025-02446-x"},{"issue":"12","key":"2592_CR96","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.2337\/dc23-0882","volume":"46","author":"LE Donovan","year":"2023","unstructured":"Donovan LE, Feig DS, Lemieux P (2023) A randomized trial of closed-loop insulin delivery postpartum in type 1 diabetes. Diabetes Care 46(12):2258\u20132266. https:\/\/doi.org\/10.2337\/dc23-0882","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"2592_CR97","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/db25-2084-LB","volume":"74","author":"LE Donovan","year":"2025","unstructured":"Donovan LE, Lemieux P, Adunlop A (2025) 2084-LB: a randomized multicenter trial of hybrid closed-loop insulin therapy with control-IQ technology in type 1 diabetes in pregnancy. Diabetes 74(Supplement_1):2084-LB. https:\/\/doi.org\/10.2337\/db25-2084-LB","journal-title":"Diabetes"},{"issue":"7","key":"2592_CR98","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2337\/dc23-0173.PMID:37196353;PMCID:PMC10300516","volume":"46","author":"CJ Levy","year":"2023","unstructured":"Levy CJ, Kudva YC, Ozaslan B, Castorino K, O\u2019Malley G, Kaur RJ, Levister CM, Church MM, Desjardins D (2023) At-Home use of a pregnancy-specific zone-MPC closed-loop system for pregnancies complicated by type 1 diabetes: a single-arm, observational multicenter study. Diabetes Care 46(7):1425\u20131431. https:\/\/doi.org\/10.2337\/dc23-0173.PMID:37196353;PMCID:PMC10300516","journal-title":"Diabetes Care"},{"key":"2592_CR99","doi-asserted-by":"publisher","first-page":"e15086","DOI":"10.1111\/dme.15086","volume":"40","author":"XS Wang","year":"2023","unstructured":"Wang XS, Dunlop AD et al (2023) Real-world use of control-IQ\u2122 technology automated insulin delivery in pregnancy: a case series with qualitative interviews. Diabet Med 40:e15086. https:\/\/doi.org\/10.1111\/dme.15086","journal-title":"Diabet Med"},{"issue":"3","key":"2592_CR100","first-page":"177","volume":"7","author":"J Moreno-Fern\u00e1ndez","year":"2021","unstructured":"Moreno-Fern\u00e1ndez J, Garc\u00eda-Seco JA (2021) Commercialized hybrid closed-loop system (Minimed Medtronic 670G) results during pregnancy. AACE Clin Case Rep 7(3):177\u2013179","journal-title":"AACE Clin Case Rep"},{"issue":"7","key":"2592_CR101","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/dia.2023.0031","volume":"25","author":"AR Dodesini","year":"2023","unstructured":"Dodesini AR, Borella ND, Lepore G, Bonfadini S, Corsi A, Scaranna C et al (2023) Real-world insulin treatment in pregnant women with type 1 diabetes using an advanced hybrid closed-loop system. Diabetes Technol Ther 25(7):516\u2013518","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"2592_CR102","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00592-024-02315-z","volume":"61","author":"R Fresa","year":"2024","unstructured":"Fresa R, Bitterman O, Cavallaro V, Di Filippi M, Dimarzo D, Mosca C et al (2024) An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes. Preliminary experience with telemedicine in 6 patients. Acta Diabetol 61(9):1185\u201394","journal-title":"Acta Diabetol"},{"issue":"2","key":"2592_CR103","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1177\/19322968231223934)","volume":"17","author":"G Petrovski","year":"2023","unstructured":"Petrovski G, Kristensen K, Olsen SE, Secher AL, Ringholm L, Damm P, Mathiesen ER (2023) Advanced hybrid closed-loop system in pregnancy: ready for prime time? J Diabetes Sci Technol 17(2):383\u2013385. https:\/\/doi.org\/10.1177\/19322968231223934)","journal-title":"J Diabetes Sci Technol"},{"key":"2592_CR104","unstructured":"ClinicalTrials.gov. Insulet Omnipod\u00ae 5 Automated Insulin Delivery (AID) System in Pregnant Women With Type 1 Diabetes. Identifier: NCT05409131. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05409131"},{"issue":"18","key":"2592_CR105","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","journal-title":"N Engl J Med"},{"key":"2592_CR106","doi-asserted-by":"publisher","DOI":"10.1177\/19322968251334397","author":"J Hand","year":"2025","unstructured":"Hand J, Levy CJ (2025) Provider perspective on automated insulin devices in pregnancy and considerations for implementation in clinical practice. J Diabetes Sci Technol. https:\/\/doi.org\/10.1177\/19322968251334397","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2592_CR107","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endrev\/bnac022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M, Nimri R, Bergenstal RM (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44(2):254\u2013280. https:\/\/doi.org\/10.1210\/endrev\/bnac022","journal-title":"Endocr Rev"},{"issue":"5","key":"2592_CR108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/dia.2022.0540","volume":"25","author":"ED Szmuilowicz","year":"2023","unstructured":"Szmuilowicz ED, Levy CJ, Buschur EO, Polsky S (2023) Expert guidance on off-label use of hybrid closed-loop therapy in pregnancies complicated by diabetes. Diabetes Technol Ther 25(5):363\u2013373. https:\/\/doi.org\/10.1089\/dia.2022.0540","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR109","doi-asserted-by":"publisher","unstructured":"Scifres CM, Walker SP et al (2025) Navigating automated insulin delivery for type 1 diabetes in pregnancy: consensus guidance. J Clin Endocrinol Metab 17:19322968251334597. https:\/\/doi.org\/10.1177\/19322968251334597. Epub ahead of print. PMID: 40243921; PMCID: PMC12006117.","DOI":"10.1177\/19322968251334597"},{"issue":"1","key":"2592_CR110","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/dia.2024.0298","volume":"27","author":"C Royston","year":"2025","unstructured":"Royston C, Bergford S, Calhoun P, Sibayan J (2025) Safety of options to \u201cBoost\u201d (enhancing insulin infusion rates) (reducing insulin infusion rates) in CamAPS FX hybrid closed-loop system: a real-world analysis. Diabetes Technol Ther 27(1):60\u201365. https:\/\/doi.org\/10.1089\/dia.2024.0298","journal-title":"Diabetes Technol Ther"},{"key":"2592_CR111","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-025-02526-y","author":"J Basset-Sagarminaga","year":"2025","unstructured":"Basset-Sagarminaga J, van den Heuvel T, Casta\u00f1eda J, Cohen O (2025) Use of the temporary glycemic target feature in the medtronic MiniMed\u2122 780G advanced hybrid closed loop system: a real-world evidence study. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-025-02526-y","journal-title":"Acta Diabetol"},{"issue":"1","key":"2592_CR112","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s13300-023-01486-2","volume":"15","author":"A Chico","year":"2024","unstructured":"Chico A, Moreno-Fern\u00e1ndez J, Fern\u00e1ndez-Garc\u00eda D, Sol\u00e1 E (2024) The hybrid closed-loop system tandem t:slim X2\u2122 with control-IQ technology: expert recommendations for better management and optimization. Diabetes Ther 15(1):281\u2013295. https:\/\/doi.org\/10.1007\/s13300-023-01486-2","journal-title":"Diabetes Ther"},{"key":"2592_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112117","volume":"223","author":"S Di Molfetta","year":"2025","unstructured":"Di Molfetta S, Rossi A, Assaloni R, Franceschi R (2025) Tips for successful use of commercial automated insulin delivery systems: an expert paper of the Italian working group on diabetes and technology. Diabetes Res Clin Pract 223:112117. https:\/\/doi.org\/10.1016\/j.diabres.2025.112117","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2592_CR114","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/dia.2020.0535","volume":"23","author":"JW Lum","year":"2021","unstructured":"Lum JW, Bailey RJ, Barnes-Lomen V, Naranjo D, Hood KK, Lal RA et al (2021) A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system. Diabetes Technol Ther 23(5):367\u2013375","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2592_CR115","doi-asserted-by":"publisher","DOI":"10.2196\/25409","volume":"23","author":"K Braune","year":"2021","unstructured":"Braune K, Gajewska KA, Thieffry A, Lewis DM, Froment T, O\u2019Donnell S et al (2021) Why #WeAreNotWaiting\u2014motivations and self-reported outcomes among users of open-source automated insulin delivery systems: multinational survey. J Med Internet Res 23(6):e25409","journal-title":"J Med Internet Res"},{"issue":"4","key":"2592_CR116","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2337\/cd20-0128","volume":"39","author":"AR Waikar","year":"2021","unstructured":"Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM (2021) Case report: managing pregnancy with type 1 diabetes using a do-it-yourself artificial pancreas system. Clin Diabetes 39(4):441\u2013444. https:\/\/doi.org\/10.2337\/cd20-0128","journal-title":"Clin Diabetes"},{"issue":"8","key":"2592_CR117","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.jcjd.2021.01.006","volume":"45","author":"P Lemieux","year":"2021","unstructured":"Lemieux P, Yamamoto JM, Donovan LE (2021) Do-it-yourself artificial pancreas system use in pregnant women with type 1 diabetes in a real-world setting: 2 case reports. Can J Diabetes 45(8):804-808.e2. https:\/\/doi.org\/10.1016\/j.jcjd.2021.01.006","journal-title":"Can J Diabetes"},{"issue":"9","key":"2592_CR118","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243522","volume":"14","author":"K Bukhari","year":"2021","unstructured":"Bukhari K, Malek R (2021) Open-source automated insulin delivery systems for the management of type 1 diabetes during pregnancy. BMJ Case Rep 14(9):e243522","journal-title":"BMJ Case Rep"},{"issue":"4","key":"2592_CR119","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2337\/cd20-0128","volume":"39","author":"AR Waikar","year":"2021","unstructured":"Waikar AR, Arora T, Haynes M, Tamborlane WV, Nally LM (2021) Case report: managing pregnancy with type 1 diabetes using a do-it-yourself artificial pancreas system. Clin Diabetes 39(4):441\u2013444","journal-title":"Clin Diabetes"},{"issue":"4","key":"2592_CR120","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1464-5491.2008.02416.x","volume":"25","author":"E Stenninger","year":"2008","unstructured":"Stenninger E, Lindqvist A, \u00c5man J, \u00d6stlund I, Schvarcz E (2008) Continuous subcutaneous glucose monitoring system in diabetic mothers during labour and postnatal glucose adaptation of their infants. Diabet Med 25(4):450\u2013454","journal-title":"Diabet Med"},{"issue":"11","key":"2592_CR121","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/dme.12246","volume":"30","author":"S Cordua","year":"2013","unstructured":"Cordua S, Secher AL, Ringholm L, Damm P, Mathiesen ER (2013) Real-time continuous glucose monitoring during labour and delivery in women with type 1 diabetes\u2014observations from a randomized controlled trial. Diabet Med 30(11):1374\u20131381","journal-title":"Diabet Med"},{"key":"2592_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111611","volume":"210","author":"F Citro","year":"2024","unstructured":"Citro F, Bianchi C, Aragona M, Belcari T, Battini L, Marchetti P et al (2024) Accuracy of intermittently scanned continuous glucose monitoring during caesarean delivery in pregnant women with insulin-treated diabetes. Diabetes Res Clin Pract 210:111611","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2592_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3248","volume":"36","author":"S Polsky","year":"2020","unstructured":"Polsky S, Akturk HK (2020) Case series of a hybrid closed-loop system used in pregnancies in clinical practice. Diabetes Metab Res Rev 36(3):e3248","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"2592_CR124","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/dia.2012.0260","volume":"15","author":"R Fresa","year":"2013","unstructured":"Fresa R, Visalli N, Di Blasi V, Cavallaro V, Ansaldi E, Trifoglio O et al (2013) Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study. Diabetes Technol Ther 15(4):328\u2013334","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"2592_CR125","doi-asserted-by":"publisher","first-page":"680.e1","DOI":"10.1016\/j.ajog.2023.07.003","volume":"229","author":"GL Wilkie","year":"2023","unstructured":"Wilkie GL, Delpapa E, Leftwich HK (2023) Intrapartum continuous subcutaneous insulin infusion vs intravenous insulin infusion among pregnant individuals with type 1 diabetes mellitus: a randomized controlled trial. Am J Obstet Gynecol 229(6):680.e1-680.e8","journal-title":"Am J Obstet Gynecol"},{"issue":"25","key":"2592_CR126","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1080\/14767058.2021.2004114","volume":"35","author":"G Wilkie","year":"2022","unstructured":"Wilkie G, Orr L, Leung K, Leftwich H (2022) Comparison of intrapartum glycemic management strategies in pregnant women with type 1 diabetes mellitus. J Matern Fetal Neonatal Med 35(25):8756\u20138760","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"11","key":"2592_CR127","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.2337\/dc24-1320","volume":"47","author":"K Beunen","year":"2024","unstructured":"Beunen K, Gillard P, Van Wilder N, Ballaux D, Vanhaverbeke G (2024) Advanced hybrid closed-loop therapy compared with standard insulin therapy intrapartum and early postpartum in women with type 1 diabetes: a secondary observational analysis from the CRISTAL randomized controlled trial. Diabetes Care 47(11):2002\u20132011","journal-title":"Diabetes Care"},{"issue":"3","key":"2592_CR128","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S2213-8587(24)00340-1","volume":"13","author":"TTM Lee","year":"2025","unstructured":"Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, Hunt KF, McCance DR, Reynolds RM, Wilinska ME, Sibayan J, Kollman C, Hovorka R, Murphy HR, AiDAPT Collaborative Group (2025) Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study. Lancet Diabetes Endocrinol 13(3):210\u2013220","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2592_CR129","doi-asserted-by":"crossref","unstructured":"Donovan LE, Feig DS, Lemieux P, Murphy HR, Bell RC, Sigal RJ et al (2023) A randomized trial of closed-loop insulin delivery postpartum in type 1 diabetes. Diabetes Care 46(12):2258\u20132266","DOI":"10.2337\/dc23-0882"},{"key":"2592_CR130","doi-asserted-by":"crossref","unstructured":"Quintanilha M, Yamamoto JM, Aylward B, Feig DS, Lemieux P, Murphy HR et al (2024) Women\u2019s and partners\u2019 experiences with a closed-loop insulin delivery system to manage type 1 diabetes in the postpartum period. Can J Diabetes 48(8):502-509.e2","DOI":"10.1016\/j.jcjd.2024.08.005"},{"key":"2592_CR131","doi-asserted-by":"crossref","unstructured":"Donovan LE, Bell RC, Feig DS, Lemieux P, Murphy HR, Sigal RJ et al (2024) Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes. Diabetologia 67(10):2154\u20132159","DOI":"10.1007\/s00125-024-06227-z"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02592-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02592-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:06:34Z","timestamp":1781651194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02592-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":133,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2592"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02592-2","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}